Discovery Europe 2025

18/07/24 - This article outlines two examples of partnerships that aim to tackle the global issue of anti-microbial resistance. This overlooked yet prominent threat continues to pose challenges for scientists, policymakers, and governments.

Overview Drug Discovery Summit & Discovery Chemistry Neuroscience Drug Development SmartLabs Automation & Robotics

Explore Discovery Europe 2025: Guiding Biopharma From Target Identification To Clinical Candidate

Discovery Europe 2025 features the co-location of 23rd Annual Drug Discovery Summit & Discovery Chemistry Europe and the 6th Annual Neuroscience Drug Development Europe Congresses.

Join and network with 1000 industry discovery biology and chemistry leaders at the renowned Drug Discovery Summit in Basel, where they address critical strategies in target identification, validation and HIT optimisation of small and large molecule drugs. The Drug Design & Medicinal Chemistry focused event also offer insightful innovations in Automation And Synthesis In Organic Chemistry as well as Molecular Drug Design.

Together with Neuroscience Drug Development Europe, attendees especially benefit from an event addressing emerging strategies for the drug development of neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative diseases.

Download Agenda

23rd Annual Drug Discovery Summit & Discovery Chemistry Europe Congress

Join and network with over 230 industry leaders at the renowned Drug Discovery Summit in Basel, where we will address the latest advancements in target identification, validation and HIT optimisation. The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics - based discovery, Organ-on-a-chip and 3D modelling. Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.

The programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
Learn about key focus areas in drug design including AI in drug design: in chemical synthesis, target ID capabilities & lead identification/optimisation.
Join our innovation showcase situated alongside the main programme, which aims to inspire growth and create collaboration opportunities for all who attend.

Agenda at a Glance

Workshop 1: Organ Modelling
Workshop 2: Targeted Protein Degradation
Workshop 3: Automation or AI in Medicinal Chemistry and Drug Design

Drug Discovery Summit

Day One | Track 1: Identification And Validation Of Novel Targets For Next Generation Therapeutics
Day One | Track 2: Animal And Disease Modelling, Organoid And Organ On The Chip Based Discovery
Day One | Track 3: Discovery on Target – Screening and Genomic Strategies
Day Two | Track 1: Phenotypic & Target Based Discovery Approaches

Drug Design & Medicinal Chemistry Summit

Day One | Track 1: Computational Drug Design: AI In Chemical Synthesis, Target ID Capabilities, Lead Identification, Lead Optimisation, Measuring PK/PD & Prediction
Day Two | Track 2: Hit Finding Technologies And Advancements
Day Two | Track 3, Part 1: Automation And Synthesis In Organic Chemistry
Day Two | Track 3, Part 2: Molecular Drug Design And Med Chem: Innovations In Fragment & Structured Based Drug Discovery

Download Agenda

6th Annual Neuroscience Drug Development Europe Congress

Addressing emerging strategies for the drug development of neuroscience and successful approaches for more targeted, precise, and transformative therapies to neurodegenerative diseases.

Examine the latest advancements and emerging trends in developing neurological treatments, including targeted approaches and novel strategies.
Discuss the pioneering innovations in stem cell technologies, with the latest updates on iPS cells for disease modelling and drug discovery.
Establish in-depth knowledge of cutting-edge recent advances in gene therapy for CNS drug discovery and current opportunities for digital biomarkers in neuroscience.

Agenda at a Glance

Day One | Track 1: Therapeutic Strategies, Enabling Technologies & Biomarker Development

Day Two | Track 1: Drug Discovery For Neurodegenerative Disease

Download Agenda

4th Annual SmartLabs Automation & Robotics Congress

The programme features the innovation and advancement in mobile robot technology and applications, and competitive advantages that can be gained in drug development and pharma manufacturing, automation and logistics.
Learn about key focus areas in developments in the automation & digitisation of QA/QC labs, accelerating digital transformation, lab robotics & tools for drug discovery workflows, robotic, process automation and implementing AI/ML in the lab.

Agenda at a Glance

Day One | Track 1: Bridging The Gap Between Automation & Digitalisation through FAIR & Digital Transformation

Day One | Track 2: Smart Manufacturing & Digitisation Optimisation

Day One | Track 3: Mobile Robotics In R&D Laboratories

Day Two | Track 1: Automation with AI/ML & Robotics Tools in Drug Discovery & Development

Day Two | Track 2: Data-Driven Modelling & Data Analytics for Drug Discovery & Development

Download Agenda

Good number of 1-1 meetings with relevant people. Very happy with the networking process and the Oxford Global team are very nice and service minded.

Regional Sales Director
AxionBio

Absolutely outstanding conference attracting large pharma and aspiring biotechs. Oxford Global are excellent, the food is outstanding and the preset meetings are informal and impactful

Vice President of Business Development
Arctoris

The organisation was perfect. Good mix between excellent scientific presentations and network opportunities.

Pharmacology Associate Director
Novalix

This was my first time at the conference and it was a great experience. Very well organized conference and I learned a lot and made valuable connection - Thank you Oxford Global.

Senior Principal Scientist
Novartis

1000

leading pharma, biotech & academic delegates

hours of presentations, discussions & interactive content

hours of networking breaks, including speed networking & refreshments

240

pre-arranged 1-2-1 meetings, facilitating business growth

What to Expect Engaging Thought Leadership

What to Expect Global Technological Showcase

What to Expect Innovative Poster Displays

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

Engaging Thought Leadership

Over 100 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
Global Technological Showcase

An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
Networking Emphasis

Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
Innovative Poster Displays

Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Today’s biopharma leaders must balance two priorities – acceleration (reducing the time from target ID to clinical candidate without compromising safety & efficacy) and innovation (bringing a consistent pipeline of novel drugs to market for difficult to treat diseases). This is at the heart of the 2025 programme, where we explore the newest methods, tools and strategies that will support scientists developing innovative therapeutics at speed. Expect:

Scientific & technical case studies highlighting best practice in every stage of the early R&D pipeline
Spotlights on novel targets making a splash – from small molecules beyond RO5 to innovative biologics
Deep dives on disease areas with the most unmet need, including a spotlight on targeting Neuroscience
Practical examples on how to implement automation & AI within R&D to improve lab productivity

Join engaging presentations featured in our innovation and collaboration track running across day 2 and 3, inspiring growth and creating space for collaboration opportunities for all who attend. The core attendee mix includes early-stage and emerging biotech or (academic) spinoff companies developing their own platforms or technologies with fewer than 30 employees.

The Innovation & Collaboration track will be comprising of 10-minute presentations and focused panel discussion sessions, encouraging networking, facilitating collaborations & showcasing emerging innovations in biomarkers discovery & development.

Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 20th December 2024
ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows:

Register and submit an abstract by 20th December 2024 using the registration link to the left on this page
Once registered you will be provided with the online abstract submission form
Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.)
The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event
The winners’ 10-minute oral presentations will take place during the networking drinks on day 2

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the Biomarkers series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights.

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Discovery Europe 2024: 22 - 23 May 2024, Basel, Switzerland

Berengere Dumotierd

Associate Director,

NOVARTIS

Davide Gianni

Senior Director,

AstraZeneca

Geoffrey Kerchner

Vice President,

F. Hoffmann-La Roche, Ltd.

Irene Choi

Head of Drug Discovery,

Verge Genomics

Janet Brownlees

Senior Director,

Merck Sharpe and Dohme

Johan Luthman

Executive Vice President of Research & Development,

Lundbeck

nils jakob vest hansen

ceo,

Vipergen ApS

Oliver Hucke

Associate Director,

Boehringer Ingelheim

Sanne Glad

Scientific Director,

Amgen Research Copenhagen

Simona Cotesta

Director,

Novartis

Show More Speakers

Hide Speakers

Amelie Joffrin

Investigator,

GSK

Anna Vulpetti

Associate Directir,

Novartis

Anto Pavlovic

Principal Research Associate,

Hoffmann La Roche Ltd

Arianna Sabò

Head of Research & Development,

QUANTRO Therapeutics

Ashutosh Dhingra

Staff scientist,

German Center for Neurodegenerative Diseases (DZNE)-Tübingen

Borislav Dejanovic

Senior Director,

Vigil Neuroscience

Carl Poelking

Associate Director,

Astex

CB Gurumurthy

Professor and Director,

University of Nebraska Medical Center

Daohong Zhou

Professor,

UTHSA

David Bearss

Chief Executive Officer,

Halia Therapeutics

Diana Zindel

Associate Director,

AstraZeneca

Eileen Wegner

Research Associate,

NMI Naturwissenschaftliches und Medizinisches Institut

Emma Davies

Associate Director - Preclinical,

Healx

Eric Goedken

Senior Principal Scientist,

AbbVie

Filip Roudnicky

Senior Principal Scientist,

Roche

Gebhard Thoma

Associate Director,

Novartis

Gergely Toth

Chief Executive Officer & Chief Scientific Officer,

Cantabio Pharmaceuticals

Giovanni Spagnolli

Chief Technology Officer,

Sibylla Biotech

Graham Dempsey

Chief Scientific Officer,

Quiver Bioscience

Gregori Gerebtzoff

Director,

Novartis

Hai Rao

Professor and Chair of Biochemistry,

Southern University of Science and Technology

James Overell

Group Medical Director,

Roche

Jon Lea

Team Leader,

GSK

Jonathan Mason

Senior Research Advisor,

Design for Drug Discovery

Jose Luis Molinuevo

Vice President Head of Experimental Medicine,

H. Lundbeck A/S

Julian Röwe

Senior Scientist,

AbbVie

Kerstin Hofer

Senior Scientist,

Roche

Manuel Stritt

Head Scientific Computing Drug Discovery,

Idorsia Pharmaceuticals

Markus Schade

Principal Scientist,

AstraZeneca

Morten Grunnet

Vice President, Head of Neuroscience and Professor,

H. Lundbeck A/S

Olivier Loiseleur

Senior Team Leader,

Syngenta

Olivier Kitten

Founder and Chief Executive Officer,

Affilogic

Olivier Bugaud

Senior Scientist Assay Development & Technologies,

Galapagos

Paulina Kolasinska-Zwierz

Principal Scientist,

Alchemab

Peter Brandt

Head of Chemistry,

Beactica Therapeutics AB

Richard Lewis

Director,

Novartis

Robin Loving

Chief Scientific Officer,

Salipro Biotech AB

Simon Huet

Senior Scientist,

Affilogic

Takhar Kasumov

Associate Professor,

NEOMED

Ulrike Künzel

Associate Principal Scientist,

Astrazeneca

Urs Langen

Laboratory Head,

Roche

Xinxin Gao

Principal Scientific Manager,

Genentech

Building Partnerships & Fostering An Inter-Disciplinary Approach In The Fight Against Anti-Microbial Resistance

This article outlines two examples of partnerships that aim to tackle the global issue of anti-microbial resistance. This overlooked yet prominent threat continues to pose challenges for scientists, policymakers, and governments.

Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration

A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024

Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling

A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024

Alzheimer's & Brain Awareness Month Spotlight: How Amphista Therapeutics is Tackling Neurological Disorders

To honour Alzheimer's & Brain Awareness Month, this article will acknowledge Amphista Therapeutics' use of targeted protein degradation (TPD) to treat symptoms of neurological disorders.

In-Person & Online Events

Online Activities

Speakers

Sponsors

Media Partners

In-Person Services

Digital Marketing Services

Browse All Resources

Latest Resources

Building Partnerships & Fostering An Inter-Disciplinary Approach In The Fight Against Anti-Microbial Resistance

Featured Resource

Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration

Discovery Europe 2025

Discovery Europe 2025

23rd Annual Drug Discovery Summit & Discovery Chemistry Europe Congress

Agenda at a Glance

6th Annual Neuroscience Drug Development Europe Congress

Agenda at a Glance

4th Annual SmartLabs Automation & Robotics Congress

Agenda at a Glance

What to Expect

Engaging Thought Leadership

Global Technological Showcase

Networking Emphasis

Innovative Poster Displays

Introducing our 2025 Summit Theme: Innovation at Speed

Companies Represented Include

Biotech Innovation & Collaboration

Inspiring Tomorrow's Breakthroughs: Unleashing Innovation & Collaboration in Discovery Research & Development

Featuring Attendees from Biotech and/or (Academic) Spinoff Companies Interested In:

2025 Young Scientist Awards (YSA) for Best Poster Presentation

Meet Our Expert Speakers

Meet Our Esteemed Sponsors

Gold Sponsors

Silver Sponsors

Network & Programme Sponsors

Interested in Sponsoring?

Latest Resources

Building Partnerships & Fostering An Inter-Disciplinary Approach In The Fight Against Anti-Microbial Resistance

Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration

Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling

Alzheimer's & Brain Awareness Month Spotlight: How Amphista Therapeutics is Tackling Neurological Disorders

Euroscreen Fast Assay Development and High-Throughput Screening Services

Pelago Bioscience - CETSA® Technology

Plan Your Visit

Register Your Interest